Harnessing Immune Power to Knock Out Leukemia | The Children's Inn at NIH скачать в хорошем качестве

Harnessing Immune Power to Knock Out Leukemia | The Children's Inn at NIH

Read the story: https://childrensinn.org/harnessing-i... Today, the majority of children diagnosed with acute lymphoblastic leukemia (ALL), the most commonly occurring childhood cancer, are cured. Yet some young patients don’t respond to chemotherapy, and in others, the cancer returns, sometimes again and again. Through an approach called adoptive cell transfer, CAR-T therapy, short for chimeric antigen receptor T-cells, scientists have unveiled cancer immunotherapy. Doctors now can use a cancer patient’s own immune system – one of the most powerful disease-fighters known to medicine – to attack his or her own cancer like it would an infection. Watch as Nirali Shah, M.D., a physician researcher at the National Cancer Institute (NCI), discusses the progress being made through her work on a clinical study based on this treatment. Dr. Shah and the team within the Pediatric Oncology Branch at NCI believe in a holistic approach to care that includes their patients’ medical and psychosocial well-being. “For a typical patient who comes here to enroll in one of our CAR-T cell trials, they’re coming here for about six to eight weeks,” says Dr. Shah. “This work couldn’t be done, quite frankly, without The Children’s Inn. We are taking patients away from their homes, away from their families, and [The Inn] is their home away from home. We really enjoy the partnership with The Children’s Inn because they help provide such a tremendous support system and an outlet for helping us support our patients as a whole person.” Learn more about how The Children's Inn supports the groundbreaking research that takes place at the National Institutes of Health on our website: https://childrensinn.org/about-the-in...